Meeder Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.94M Buy
8,014
+314
+4% +$170K 0.16% 84
2025
Q4
$4.46M Buy
7,700
+277
+4% +$157K 0.19% 76
2025
Q3
$3.6M Buy
7,423
+919
+14% +$428K 0.17% 93
2025
Q2
$2.64M Sell
6,504
-792
-11% -$331K 0.14% 117
2025
Q1
$3.63M Buy
7,296
+212
+3% +$115K 0.22% 73
2024
Q4
$3.69M Sell
7,084
-181
-2% -$99.5K 0.23% 67
2024
Q3
$4.49M Sell
7,265
-145
-2% -$85.8K 0.29% 54
2024
Q2
$4.1M Buy
7,410
+2,005
+37% +$1.15M 0.29% 52
2024
Q1
$3.14M Buy
5,405
+386
+8% +$217K 0.32% 49
2023
Q4
$2.66M Sell
5,019
-238
-5% -$115K 0.31% 54
2023
Q3
$2.66M Sell
5,257
-633
-11% -$337K 0.33% 48
2023
Q2
$3.07M Sell
5,890
-563
-9% -$304K 0.33% 48
2023
Q1
$3.72M Buy
6,453
+390
+6% +$220K 0.43% 38
2022
Q4
$3.34M Buy
+6,063
New +$3.21M 0.42% 42

Other funds holding TMO

Meeder Advisory Services's TMO Position: Q1 2026 in Review

Meeder Advisory Services increased its Thermo Fisher Scientific (TMO) stake by 4.1% in Q1 2026, buying an estimated $170K and bringing the position to 8,014 shares worth $3.94M. The position accounts for 0.16% of the portfolio, ranked #84.

Meeder Advisory Services first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.49M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Meeder Advisory Services held 8,014 shares of Thermo Fisher Scientific worth $3.94M as of Q1 2026.
  • Meeder Advisory Services bought 314 Thermo Fisher Scientific shares in Q1 2026, an estimated $170K.
  • Thermo Fisher Scientific made up 0.16% of Meeder Advisory Services's portfolio in Q1 2026, its #84 holding.
  • Meeder Advisory Services first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
  • Meeder Advisory Services's Thermo Fisher Scientific position peaked at $4.49M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.